Single Arm Phase II Trial of Elective Nodal Dose Reduction for Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck

To evaluate a novel chemoradiotherapy (CRT) regimen for patients with squamous cell carcinoma of the head and neck (SCCHN) incorporating a lower intensity modulated radiation therapy (IMRT) dose to electively treated neck lymph nodes than is currently standard.

http://ift.tt/2DsKcOn